This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated COMP Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-COMP WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~82.9 kDa | |
| Observed band | 110 kDa | |
| Gel | 8–10% | |
| Negative control | siRNA / KO lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | N-glycosylation | |
| Regulation | Coagulation | |
| Isoform | 2 isoform(s) |
Literature-validated Western blot parameters for COMP — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human HepG2 , Lane 2: human Hacat , Lane 3: human CACO-2 , Lane 4: human 293T , Lane 5: rat cartilage , Lane 6: mouse cartilage . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-COMP antigen affinity purified polyclonal antibody (Catalog # A02443-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for COMP at approximately 110 kDa. The expected band size for COMP is at 83 kDa |
| Gel % | 8–10% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 110 kDa |
COMP has an 82.9 kDa predicted backbone but runs at ~110 kDa on reducing blots due to N-linked glycosylation at two sites, with disulfide-linked pentamers appearing far higher if unreduced.
| single band near 110 kDa under reducing conditions | the glycosylated COMP monomer, elevated well above the 82.9 kDa predicted mass by N-linked glycosylation at Asn121 and Asn742 |
| band smearing or fuzziness around 100-120 kDa | heterogeneous carbohydrate loading across the two N-linked glycosylation sites broadening the monomer band |
| very high molecular weight band at or near the top of the gel or trapped in the stacking gel | the intact disulfide-linked pentamer running at roughly five times monomer mass because reduction was incomplete |
| little or no band in whole-cell lysate | COMP is secreted into the extracellular matrix, so a whole-cell lysate captures only the intracellular biosynthetic pool rather than the mature secreted protein |
| monomer band slightly smaller than the glycosylated full-length precursor | removal of the 20-residue signal peptide during secretion to yield the mature form |
| predicted mass (UniProt, 82.9 kDa) | sets the unmodified polypeptide baseline before any processing or modification is accounted for |
| N-glycosylation at Asn121 and Asn742 | adds carbohydrate mass, shifting the observed reduced monomer up to roughly 110 kDa |
| signal peptide cleavage (residues 1-20) | removes the N-terminal signal sequence during secretion, slightly lowering mature protein mass relative to the unprocessed precursor |
| disulfide-linked pentamer assembly | under non-reducing or incompletely reduced conditions the intact oligomer migrates at roughly five times monomer mass near the top of the gel instead of the ~110 kDa monomer |
| isoforms 1 and 2 (alternative splicing) | can shift the monomer band slightly relative to the canonical form, described only qualitatively since no per-isoform mass is defined |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | COMP is secreted into the extracellular space and matrix, so whole-cell lysate largely misses the mature extracellular pool | probe conditioned media or an extracellular matrix extraction instead of relying solely on whole-cell lysate |
| Band higher than expected | incomplete reduction leaves the disulfide-linked pentamer or partial oligomeric intermediates intact | increase reducing agent concentration and boil the sample longer to fully resolve the ~110 kDa monomer |
| Broad smear instead of sharp band | heterogeneous glycosylation across the two N-linked sites produces a range of glycoform masses | treat the sample with PNGase F to deglycosylate and sharpen the band, or extend separation on a lower-percentage gel |
| Multiple bands | co-migration of isoform 1 and isoform 2, or partially reduced oligomeric species alongside the monomer | confirm isoform identity with sequence-specific detection and verify complete denaturation and reduction of the sample |
| Fragments below expected size | proteolytic degradation of the secreted extracellular matrix protein during tissue or matrix extraction | include protease inhibitors and keep extracellular matrix samples cold and freshly processed |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for COMP, answered from its protein features.
BosterBio's COMP antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
The anti-COMP antibody below is Boster's top-performing option for cartilage oligomeric matrix protein detection, extensively cited and rigorously validated by western blot, with specificity confirmed against negative-control tissue and orthogonal detection methods for reliable, reproducible results.
Which to pick: Only A02443-1 is catalogued for COMP, backed by an actual western blot validation image, so it's the clear choice; no alternative clones are currently listed for comparison.